Bayer boosted by Schering integration
March 4, 2009Sales and Marketing Bayer
Profits at Bayer's healthcare division rose by 10% to 4.1 billion euros last year as it increasingly felt the benefits …
FDA puts block on Ranbaxy products
March 4, 2009Manufacturing and Production Ranbaxy
India’s Ranbaxy Laboratories has been dealt another blow by the FDA after the agency suspended regulatory review of any products …
First-in-class cancer treatment Vidaza launched
March 3, 2009Research and Development Vidaza
Vidaza, an innovative new treatment for a number of hard-to-treat blood cancers, has been launched in the UK by Celgene. …
Roche and Bayer Schering ‘named and shamed’ for Code breaches
March 3, 2009Sales and Marketing ABPI, Code of Practice
Roche and Bayer Schering Pharma have been publically reprimanded for bringing discredit upon the UK pharma industry.Bayer fell foul of …
Darzi plans for a faster NICE process
March 3, 2009NHS
Health minister Lord Darzi has unveiled proposals that would see the NICE appraisal process speeded up considerably. NICE has been …
Grabbing the Gorilla: Making adverts sell
March 3, 2009Medical Communications, Sales and Marketing advertising, branding
Awareness, persuasion and emotional appeal are all important factors in effective advertising. The key is to draw attention to the …
Contract manufacturing could profit from downturn
March 2, 2009Manufacturing and Production Kalorama
The market for contract manufacturing of prescription drugs exceeded $30 billion last year, a 10% increase that is being fuelled …
Chinese move marks ‘globalisation’ of Bayer Schering R&D
March 2, 2009Research and Development Asia, Bayer, China
Bayer Schering Pharma's plan to build a 100 million-euro R&D centre in Beijing marks the company's first major foray into …
Making remote working work
February 27, 2009Business Services remote working
There can be all sorts of reasons to work from home, from the usual, such as fitting work around the …
Novartis vaccine recalled after contamination scare
February 26, 2009Manufacturing and Production, Research and Development Vaccine
Novartis has recalled UK supplies of its meningitis C vaccine after tests found some batches contaminated with bacteria. The recall …
Almirall in talks with potential asthma partners
February 26, 2009Sales and Marketing Almirall, COPD
Spanish pharma company Almirall is in discussions with potential partners for one of its asthma drugs following positive trial results. …
Time running out for pharma sales and marketing
February 26, 2009Research and Development, Sales and Marketing pwC, strategy
The pharma industry's current sales and marketing model will be defunct in the next ten years. That is the stark …
Virgo wins major new diabetes launch account
February 26, 2009Medical Communications Virgo
London-based healthcare PR specialist Virgo Health has won the UK account for new diabetes drug Onglyza. Due to be launched …
Europe approves Lilly’s Plavix rival
February 25, 2009Research and Development, Sales and Marketing Daiichi, Effient, lilly
Lilly and Daiichi Sankyo have won European approval for their blood-thinning drug Efient, which will go up against established blockbuster …
Genentech urges shareholders to reject Roche bid
February 24, 2009Sales and Marketing Genentech, Roche
The battle for the future of Genentech has heated up after the company's board asked its shareholders to reject Roche's …
NovaBiotics: a rising star for 2009
February 24, 2009Research and Development NovaBiotics
Biologics company NovaBiotics has been dubbed a Rising Star for 2009 by the Scottish arm of the BioIndustry Association. The …
R&D tax credits among anticipated changes for US healthcare
February 24, 2009Research and Development US, healthcare
With the election of Barack Obama, widespread changes are anticipated for US healthcare and ultimately for the pharmaceutical industry. Although …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
